Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Bethany Kwan and Neil Aggarwal.
|
|
Connection Strength |
|
 |
|
 |
|
0.524 |
|
|
|
-
Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Davis CB, Kwan BM, Mayer DA, Ong TC, Russell S, Steele J, Wogu AF, Wynia MK, Zane RD, Ginde AA. Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. J Infect Dis. 2022 12 13; 226(12):2129-2136.
Score: 0.209
-
Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Davis CB, Kwan BM, Mayer DA, Ong TC, Russell S, Steele J, Wogu AF, Wynia MK, Zane RD, Ginde AA. Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. medRxiv. 2022 Apr 05.
Score: 0.199
-
Xiao M, Molina KC, Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Fish LE, Hamer MK, Kwan BM, Mayer DA, Peers JL, Wynia MK, Ginde AA. A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies. JAMA Health Forum. 2024 Sep 06; 5(9):e242884.
Score: 0.059
-
Roberts SC, Jolley SE, Beaty LE, Aggarwal NR, Bennett TD, Carlson NE, Fish LE, Kwan BM, Russell S, Wogu AF, Wynia MA, Ginde AA. Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19. J Med Virol. 2024 Mar; 96(3):e29541.
Score: 0.057
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|